Free Trial

Captrust Financial Advisors Buys 5,673 Shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Ryan Specialty logo with Finance background

Captrust Financial Advisors grew its stake in shares of Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 60.3% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund owned 15,078 shares of the company's stock after buying an additional 5,673 shares during the period. Captrust Financial Advisors' holdings in Ryan Specialty were worth $967,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors have also modified their holdings of RYAN. Barclays PLC lifted its holdings in shares of Ryan Specialty by 1.1% during the 3rd quarter. Barclays PLC now owns 1,641,743 shares of the company's stock valued at $108,994,000 after purchasing an additional 17,267 shares in the last quarter. UMB Bank n.a. lifted its holdings in shares of Ryan Specialty by 5.7% during the 4th quarter. UMB Bank n.a. now owns 5,522 shares of the company's stock valued at $354,000 after purchasing an additional 298 shares in the last quarter. SG Americas Securities LLC lifted its stake in Ryan Specialty by 94.2% in the 4th quarter. SG Americas Securities LLC now owns 3,253 shares of the company's stock valued at $209,000 after acquiring an additional 1,578 shares in the last quarter. Janney Montgomery Scott LLC lifted its stake in Ryan Specialty by 4.9% in the 4th quarter. Janney Montgomery Scott LLC now owns 17,825 shares of the company's stock valued at $1,144,000 after acquiring an additional 831 shares in the last quarter. Finally, Avior Wealth Management LLC lifted its stake in Ryan Specialty by 2,113.3% in the 4th quarter. Avior Wealth Management LLC now owns 3,497 shares of the company's stock valued at $224,000 after acquiring an additional 3,339 shares in the last quarter. Institutional investors own 84.82% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have commented on RYAN. Wells Fargo & Company cut their target price on Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 10th. UBS Group boosted their target price on Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a research note on Wednesday, February 26th. The Goldman Sachs Group raised Ryan Specialty from a "neutral" rating to a "buy" rating and boosted their price target for the stock from $74.00 to $81.00 in a research report on Tuesday, May 13th. Morgan Stanley boosted their target price on Ryan Specialty from $78.00 to $80.00 and gave the stock an "overweight" rating in a report on Monday. Finally, Barclays decreased their price objective on Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating on the stock in a report on Friday, April 11th. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating and eight have assigned a buy rating to the company. According to MarketBeat.com, the stock has an average rating of "Moderate Buy" and an average target price of $75.58.

View Our Latest Analysis on Ryan Specialty

Ryan Specialty Trading Down 0.6%

NYSE RYAN traded down $0.46 during trading hours on Wednesday, hitting $70.13. 46,942 shares of the company's stock were exchanged, compared to its average volume of 977,055. The stock has a 50-day simple moving average of $70.22 and a 200 day simple moving average of $68.78. Ryan Specialty Holdings, Inc. has a 1-year low of $52.34 and a 1-year high of $77.16. The firm has a market cap of $18.40 billion, a price-to-earnings ratio of 101.86, a PEG ratio of 1.19 and a beta of 0.68. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The company reported $0.39 EPS for the quarter, meeting analysts' consensus estimates of $0.39. The firm had revenue of $690.17 million during the quarter, compared to analysts' expectations of $680.80 million. Ryan Specialty had a return on equity of 48.01% and a net margin of 9.14%. The company's revenue for the quarter was up 25.0% compared to the same quarter last year. During the same quarter last year, the firm posted $0.35 earnings per share. On average, equities analysts forecast that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current fiscal year.

Ryan Specialty Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, May 27th. Stockholders of record on Tuesday, May 13th will be given a dividend of $0.12 per share. The ex-dividend date is Tuesday, May 13th. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.68%. Ryan Specialty's dividend payout ratio is presently 141.18%.

Insider Activity

In related news, EVP Brendan Martin Mulshine sold 30,000 shares of the business's stock in a transaction on Friday, March 14th. The stock was sold at an average price of $69.30, for a total transaction of $2,079,000.00. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders own 11.10% of the company's stock.

About Ryan Specialty

(Free Report)

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.

Further Reading

Institutional Ownership by Quarter for Ryan Specialty (NYSE:RYAN)

Should You Invest $1,000 in Ryan Specialty Right Now?

Before you consider Ryan Specialty, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.

While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth
4 Biotech Stocks on the Verge of Massive Breakthroughs

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines